Effectiveness of intravenous propafenone for conversion of recent-onset atrial fibrillation: a placebo-controlled study

Clinical Cardiology
F BellandiR P Dabizzi

Abstract

To evaluate the efficacy of propafenone in converting recent-onset atrial fibrillation (AF) lasting < 7 days, 182 patients were treated intravenously with propafenone (Group 1, n = 98) and with placebo 0.9% saline solution (Group 2, n = 84) in a double blind study. The treatment was continued until sinus rhythm (SR) was restored, but for no more than 24 h. Eighty-nine patients treated with propafenone (90.8%) and 27 patients treated with placebo (32.1%) responded to the treatment and SR was restored (p < 0.0005). The mean time for SR restoration was 2.51 +/- 2.77 h in Group 1, and 17.15 +/- 7.8 h in Group 2 (p < 0.0005). In both groups the patients in whom SR was not restored (nonresponders) had larger left atrial size and longer duration of AF than responders at the onset of the arrhythmia. Nonresponders in Group 1 showed a decrease in mean ventricular rate (MVR) from 143 +/- 16 to 101 +/- 18 (p < 0.0005), while in the nonresponders in Group 2 no reduction of MVR was observed. Two patients whose SR was restored with propafenone had sinus standstill lasting 3.4 and 3.8 s, respectively. Propafenone used intravenously is an effective, quick, and safe drug for treating AF. Moreover, it significantly reduces MVR in nonresponders.

References

Sep 15, 1990·The American Journal of Cardiology·C J MurdockC R Kerr
Mar 1, 1987·The American Journal of Cardiology·I G CrozierL Levy
Aug 25, 1988·The American Journal of Cardiology·J L AndersonP A Fredell
Mar 1, 1987·European Heart Journal·M Schlepper
Jun 1, 1987·Journal of the American College of Cardiology·S C HammillD R Holmes
Feb 1, 1985·Australian and New Zealand Journal of Medicine·T P GavaghanJ J Morgan
Mar 11, 1972·British Medical Journal·L SchamrothC Garrett
Dec 1, 1980·American Heart Journal·R A DeSilvaB Lown
Jul 1, 1954·American Heart Journal·L R PASCALEE F FOLEY
Nov 1, 1964·The American Journal of Medicine·J W HURSTR C SCHLANT

❮ Previous
Next ❯

Citations

Nov 11, 1998·The American Journal of Cardiology·A P Rae
Jan 22, 2003·Journal of the American College of Cardiology·Philippe ChevalierPaul Touboul
Nov 6, 2002·The American Journal of Geriatric Cardiology·Mark Dayer, Suzanna M C Hardman
May 19, 1998·Pacing and Clinical Electrophysiology : PACE·C CosteasJ A Reiffel
Nov 18, 1997·Journal of Cardiovascular Electrophysiology·L I Ganz, E M Antman
Jan 22, 2005·Annual Review of Medicine·Ashish AgarwalMichael Ezekowitz
Jan 13, 2001·Seminars in Thoracic and Cardiovascular Surgery·R W RhoD Kocovic
Dec 24, 1997·Cardiology Clinics·F A Masoudi, N Goldschlager
Oct 17, 1996·The American Journal of Cardiology·B Olshansky
Nov 5, 2003·Expert Opinion on Pharmacotherapy·Paul A GouldDavid M Kaye
Nov 10, 2016·Medicine·Mariya NegrevaKaterina Vitlianova
Mar 16, 2001·Expert Opinion on Pharmacotherapy·J Nemec, W K Shen
Feb 23, 2000·Journal of Cardiovascular Pharmacology and Therapeutics·M Valderrábano, B N Singh
Dec 22, 2000·Current Opinion in Cardiology·A Pinter, P Dorian
Jan 6, 2021·Cardiovascular Drugs and Therapy·Dimitris TsiachrisChristodoulos Stefanadis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.